UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers

Molecular endocrinology (Baltimore, Md.), 2012-03, Vol.26 (3), p.360-371

2012

Volltextzugriff (PDF)

Emerging Roles of Ceramides in Breast Cancer Biology and Therapy

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11178

2022

Volltextzugriff (PDF)

An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors

PloS one, 2011-07, Vol.6 (7), p.e22274

2011

Volltextzugriff (PDF)

SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2019-11, Vol.116 (47), p.23534-23541

2019

Volltextzugriff (PDF)

Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4), p.974-984

2018

Volltextzugriff (PDF)

Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells

Molecular cell, 2017-03, Vol.65 (6), p.1122-1135.e5

2017

Volltextzugriff (PDF)

Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells

Breast cancer research : BCR, 2022-03, Vol.24 (1), p.19-19, Article 19

2022

Volltextzugriff (PDF)

Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors

Breast cancer research : BCR, 2022-12, Vol.24 (1), p.88-88, Article 88

2022

Volltextzugriff (PDF)

Identification of metabolic pathways contributing to ER+ breast cancer disparities using a machine-learning pipeline

Scientific reports, 2023-07, Vol.13 (1), p.12136-12136, Article 12136

2023

Volltextzugriff (PDF)

Full antagonism of the estrogen receptor without a prototypical ligand side chain

Nature chemical biology, 2017-01, Vol.13 (1), p.111-118

2017

Volltextzugriff (PDF)

A Cell-Permeable Stapled Peptide Inhibitor of the Estrogen Receptor/Coactivator Interaction

ACS chemical biology, 2018-03, Vol.13 (3), p.676-684

2018

Volltextzugriff (PDF)

ASCT2 is a major contributor to serine uptake in cancer cells

Cell reports (Cambridge), 2024-08, Vol.43 (8), p.114552-114552, Article 114552

2024

Volltextzugriff (PDF)

CBP Mediates NF-κB-Dependent Histone Acetylation and Estrogen Receptor Recruitment to an Estrogen Response Element in the BIRC3 Promoter

Molecular and Cellular Biology, 2012-01, Vol.32 (2), p.569-575

2012

Volltextzugriff (PDF)

Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas

PloS one, 2015-12, Vol.10 (12), p.e0145346-e0145346

2015

Volltextzugriff (PDF)

Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs

PloS one, 2017-10, Vol.12 (10), p.e0186620

2017

Volltextzugriff (PDF)

Estrogen-Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell Proliferation

Molecular endocrinology (Baltimore, Md.), 2007-09, Vol.21 (9), p.2112-2123

2007

Volltextzugriff (PDF)

The Stimulation of HSD17B7 Expression by Estradiol Provides a Powerful Feed-Forward Mechanism for Estradiol Biosynthesis in Breast Cancer Cells

Molecular endocrinology (Baltimore, Md.), 2011-05, Vol.25 (5), p.754-766

2011

Volltextzugriff (PDF)

Therapeutic targeting in the estrogen receptor hormonal pathway

Seminars in oncology, 2004-02, Vol.31 (1 Suppl 3), p.28-38

2004

Volltextzugriff (PDF)

Estrogen Down-Regulation of the Corepressor N-CoR: Mechanism and Implications for Estrogen Derepression of N-CoR-Regulated Genes

Proceedings of the National Academy of Sciences - PNAS, 2005-09, Vol.102 (37), p.13153-13157

2005

Volltextzugriff (PDF)

Update on the Role of NFKB in Promoting Aggressive Phenotypes of Estrogen Receptor-Positive Breast Cancer

Endocrinology (Philadelphia), 2020-10, Vol.161 (10), p.1

2020

Volltextzugriff (PDF)

Update on the Role of NFκB in Promoting Aggressive Phenotypes of Estrogen Receptor–Positive Breast Cancer

Endocrinology (Philadelphia), 2020-10, Vol.161 (10)

2020

Volltextzugriff (PDF)

Abstract P4-02-06: Exploiting ceramide homeostasis to target endocrine therapy-resistant breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-02-06

2022

Volltextzugriff (PDF)

A Protective Role for Triacylglycerols during Apoptosis

Biochemistry (Easton), 2018-01, Vol.57 (1), p.72-80

2018

Volltextzugriff (PDF)

Abstract 2158: Inhibition of NFkB restores tamoxifen responsiveness in resistant estrogen receptor positive breast cancer in a syngeneic mouse model

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2158-2158

2018

Volltextzugriff (PDF)

PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres

Oncogene, 2015-04, Vol.34 (18), p.2309-2316

2015

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(123)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers

Emerging Roles of Ceramides in Breast Cancer Biology and Therapy

An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors

SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer

Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer

Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells

Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells

Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors

Identification of metabolic pathways contributing to ER+ breast cancer disparities using a machine-learning pipeline

Full antagonism of the estrogen receptor without a prototypical ligand side chain

A Cell-Permeable Stapled Peptide Inhibitor of the Estrogen Receptor/Coactivator Interaction

ASCT2 is a major contributor to serine uptake in cancer cells

CBP Mediates NF-κB-Dependent Histone Acetylation and Estrogen Receptor Recruitment to an Estrogen Response Element in the BIRC3 Promoter

Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas

Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs

Estrogen-Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell Proliferation

The Stimulation of HSD17B7 Expression by Estradiol Provides a Powerful Feed-Forward Mechanism for Estradiol Biosynthesis in Breast Cancer Cells

Therapeutic targeting in the estrogen receptor hormonal pathway

Estrogen Down-Regulation of the Corepressor N-CoR: Mechanism and Implications for Estrogen Derepression of N-CoR-Regulated Genes

Update on the Role of NFKB in Promoting Aggressive Phenotypes of Estrogen Receptor-Positive Breast Cancer

Update on the Role of NFκB in Promoting Aggressive Phenotypes of Estrogen Receptor–Positive Breast Cancer

Abstract P4-02-06: Exploiting ceramide homeostasis to target endocrine therapy-resistant breast cancer

A Protective Role for Triacylglycerols during Apoptosis

Abstract 2158: Inhibition of NFkB restores tamoxifen responsiveness in resistant estrogen receptor positive breast cancer in a syngeneic mouse model

PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres

Suchergebnisse filtern